(Opioid Policy, Part Two: the US)
The new Health and Human Services secretary, Alex Azar, will will oversee a sprawling agency including of most direct relevance to TRUCE, our friends in the FDA, NIH, and Substance Abuse and Mental Health Services Administration (SAMHSA).
And, surprise, surprise (like many former heads of the FDA and other HHS key staffers with a drug co background) Azar was president of Eli Lilly USA, a global pharmaceutical company.
[*the sound of our editors’ teeth gnashing*]
He’s also been charged with “solving” the opioid crisis by the president, whose own commission on the epidemic, you may recall refused to even allow testimony on the research-demonstrated usefulness of medicinal cannabis in lessening the epidemic.
Not to mention the likelihood the FDA will continue to pretend that plants aren’t medicinal and so research into them can’t be easily done or FDA-certified when done..
#MMJ #Opioids #PatientsBeforePolitics #USpol #UTpol #TRUCE